GeneDx Holdings Corp. (United States) is listed on the Nasdaq and has a market capitalization of $2.33 billion, with shareholders equity totaling $244.22 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, GeneDx Holdings Corp. reported $454.43 million in revenue, generating net income of $-106.36 million.
Key financial metrics include a P/E ratio of -21.92, a price-to-book (P/B) ratio of 9.55, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker WGS.